In summary, these findings uncover a novel role for Nlrp12 as a key genetic determinant of uveitis susceptibility, and the cellular mechanism by which Nlrp12 protects against uveitis could be targeted as an alternative approach for treatment of ocular autoimmunity. Here, NLRP12 is linked to uveitis.